Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy

Abstract Background and aim Prognosis determination is essential for hepatocellular carcinoma (HCC) patient management and treatment planning. The current study aimed to evaluate the prognosis performance of NLR, ALBI, and the combination of NLR-ALBI in determining the overall survival (OS) of HCC p...

Full description

Bibliographic Details
Main Authors: Hao Luo, Chongming Huang, Meng Meng, Ming Zhang, Zigang Li, Jun Huang
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-023-02804-5
_version_ 1797822789636325376
author Hao Luo
Chongming Huang
Meng Meng
Ming Zhang
Zigang Li
Jun Huang
author_facet Hao Luo
Chongming Huang
Meng Meng
Ming Zhang
Zigang Li
Jun Huang
author_sort Hao Luo
collection DOAJ
description Abstract Background and aim Prognosis determination is essential for hepatocellular carcinoma (HCC) patient management and treatment planning. The current study aimed to evaluate the prognosis performance of NLR, ALBI, and the combination of NLR-ALBI in determining the overall survival (OS) of HCC patients under curative hepatectomy. Methods 144 primary HCC patients with curative hepatectomy were recruited in the retrospective study. The clinicopathologic characteristics and OS were compared between stratified groups. The predictive performance of NLR, ALBI, and the combination of NLR-ALBI was explored by the area under the receiver operating characteristic curve (AUC). Univariate and multivariate analyses were used to determine the risk factors of OS. Results AUC determined NLR cutoff > 2.60 for predicting prognosis. The univariate analysis indicated pathological differentiation, tumor size, AFP, TNM stage, NLR score, and ALBI grade were significant indicators of OS. However, only TMN grade, AFP, NLR score, and NLR-ALBI score were identified as independent predictors of OS in the multivariable analysis. The AUC of NLR, ALBI and the combination of NLR-ALBI was 0.618(95%CI 0.56–0.710), 0.533 (95%CI 0.437–0.629), 0.679 (95%CI 0.592–0.767) respectively. Patients with higher NLR-ALBI scores presented worse outcomes than those with lower NLR-ALBI scores. Conclusion NLR is an independent prognostic factor of HCC and a reliable biomarker in predicting the OS of HCC patients. The combination of NLR-ALBI showed a better prognostic performance than using NLR or ALBI alone, implicating the effectiveness and feasibility of combining multiple risk factors for postoperative prognosis assessment.
first_indexed 2024-03-13T10:14:21Z
format Article
id doaj.art-2e5e8317e85c42a9a715122eb964db0d
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-03-13T10:14:21Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-2e5e8317e85c42a9a715122eb964db0d2023-05-21T11:17:50ZengBMCBMC Gastroenterology1471-230X2023-05-012311810.1186/s12876-023-02804-5Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomyHao Luo0Chongming Huang1Meng Meng2Ming Zhang3Zigang Li4Jun Huang5Department of General Surgery, The First People’s Hospital of YibinDepartment of General Surgery, The First People’s Hospital of YibinDepartment of Gastrointestinal Surgery, Shandong Provincial Third Hospital, Shandong UniversityDepartment of General Surgery, The First People’s Hospital of YibinDepartment of General Surgery, The First People’s Hospital of YibinDepartment of General Surgery, The First People’s Hospital of YibinAbstract Background and aim Prognosis determination is essential for hepatocellular carcinoma (HCC) patient management and treatment planning. The current study aimed to evaluate the prognosis performance of NLR, ALBI, and the combination of NLR-ALBI in determining the overall survival (OS) of HCC patients under curative hepatectomy. Methods 144 primary HCC patients with curative hepatectomy were recruited in the retrospective study. The clinicopathologic characteristics and OS were compared between stratified groups. The predictive performance of NLR, ALBI, and the combination of NLR-ALBI was explored by the area under the receiver operating characteristic curve (AUC). Univariate and multivariate analyses were used to determine the risk factors of OS. Results AUC determined NLR cutoff > 2.60 for predicting prognosis. The univariate analysis indicated pathological differentiation, tumor size, AFP, TNM stage, NLR score, and ALBI grade were significant indicators of OS. However, only TMN grade, AFP, NLR score, and NLR-ALBI score were identified as independent predictors of OS in the multivariable analysis. The AUC of NLR, ALBI and the combination of NLR-ALBI was 0.618(95%CI 0.56–0.710), 0.533 (95%CI 0.437–0.629), 0.679 (95%CI 0.592–0.767) respectively. Patients with higher NLR-ALBI scores presented worse outcomes than those with lower NLR-ALBI scores. Conclusion NLR is an independent prognostic factor of HCC and a reliable biomarker in predicting the OS of HCC patients. The combination of NLR-ALBI showed a better prognostic performance than using NLR or ALBI alone, implicating the effectiveness and feasibility of combining multiple risk factors for postoperative prognosis assessment.https://doi.org/10.1186/s12876-023-02804-5Hepatocellular carcinomaPrognostic factorNeutrophil/lymphocyte ratioAlbumin/Bilirubin gradeOverall survival
spellingShingle Hao Luo
Chongming Huang
Meng Meng
Ming Zhang
Zigang Li
Jun Huang
Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
BMC Gastroenterology
Hepatocellular carcinoma
Prognostic factor
Neutrophil/lymphocyte ratio
Albumin/Bilirubin grade
Overall survival
title Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
title_full Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
title_fullStr Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
title_full_unstemmed Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
title_short Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
title_sort combination of neutrophil lymphocyte ratio and albumin bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
topic Hepatocellular carcinoma
Prognostic factor
Neutrophil/lymphocyte ratio
Albumin/Bilirubin grade
Overall survival
url https://doi.org/10.1186/s12876-023-02804-5
work_keys_str_mv AT haoluo combinationofneutrophillymphocyteratioandalbuminbilirubingradeasaprognosticpredictorforhepatocellularcarcinomapatientsundergoingcurativehepatectomy
AT chongminghuang combinationofneutrophillymphocyteratioandalbuminbilirubingradeasaprognosticpredictorforhepatocellularcarcinomapatientsundergoingcurativehepatectomy
AT mengmeng combinationofneutrophillymphocyteratioandalbuminbilirubingradeasaprognosticpredictorforhepatocellularcarcinomapatientsundergoingcurativehepatectomy
AT mingzhang combinationofneutrophillymphocyteratioandalbuminbilirubingradeasaprognosticpredictorforhepatocellularcarcinomapatientsundergoingcurativehepatectomy
AT zigangli combinationofneutrophillymphocyteratioandalbuminbilirubingradeasaprognosticpredictorforhepatocellularcarcinomapatientsundergoingcurativehepatectomy
AT junhuang combinationofneutrophillymphocyteratioandalbuminbilirubingradeasaprognosticpredictorforhepatocellularcarcinomapatientsundergoingcurativehepatectomy